Arthur M. Cohen & Associates’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.49M | Hold |
4,206
| – | – | 0.26% | 54 |
|
|
2025
Q4 | $1.38M | Sell |
4,206
-165
| -4% | -$52.3K | 0.22% | 57 |
|
|
2025
Q3 | $1.23M | Sell |
4,371
-535
| -11% | -$155K | 0.21% | 57 |
|
|
2025
Q2 | $1.37M | Sell |
4,906
-850
| -15% | -$241K | 0.24% | 56 |
|
|
2025
Q1 | $1.79M | Sell |
5,756
-1,810
| -24% | -$534K | 0.34% | 40 |
|
|
2024
Q4 | $1.97M | Sell |
7,566
-345
| -4% | -$102K | 0.35% | 39 |
|
|
2024
Q3 | $2.53M | Hold |
7,911
| – | – | 0.46% | 32 |
|
|
2024
Q2 | $2.47M | Sell |
7,911
-100
| -1% | -$29.4K | 0.45% | 32 |
|
|
2024
Q1 | $2.28M | Sell |
8,011
-760
| -9% | -$222K | 0.48% | 31 |
|
|
2023
Q4 | $2.53M | Sell |
8,771
-100
| -1% | -$27.2K | 0.59% | 31 |
|
|
2023
Q3 | $2.38M | Sell |
8,871
-1,138
| -11% | -$284K | 0.61% | 27 |
|
|
2023
Q2 | $2.22M | Sell |
10,009
-540
| -5% | -$125K | 0.55% | 28 |
|
|
2023
Q1 | $2.55M | Buy |
10,549
+310
| +3% | +$76.1K | 0.68% | 26 |
|
|
2022
Q4 | $2.69M | Sell |
10,239
-635
| -6% | -$170K | 0.73% | 27 |
|
|
2022
Q3 | $2.45M | Sell |
10,874
-800
| -7% | -$194K | 0.67% | 28 |
|
|
2022
Q2 | $2.84M | Sell |
11,674
-885
| -7% | -$217K | 0.71% | 27 |
|
|
2022
Q1 | $3.04M | Sell |
12,559
-8,990
| -42% | -$2.07M | 0.64% | 30 |
|
|
2021
Q4 | $4.84M | Sell |
21,549
-3,255
| -13% | -$687K | 0.9% | 21 |
|
|
2021
Q3 | $5.27M | Sell |
24,804
-1,621
| -6% | -$373K | 1.07% | 21 |
|
|
2021
Q2 | $6.44M | Sell |
26,425
-1,428
| -5% | -$351K | 1.25% | 17 |
|
|
2021
Q1 | $6.93M | Sell |
27,853
-1,010
| -3% | -$241K | 1.6% | 14 |
|
|
2020
Q4 | $6.64M | Sell |
28,863
-110
| -0.4% | -$25.4K | 1.56% | 14 |
|
|
2020
Q3 | $7.36M | Buy |
28,973
+336
| +1% | +$83.2K | 1.91% | 11 |
|
|
2020
Q2 | $6.75M | Sell |
28,637
-456
| -2% | -$104K | 2.04% | 13 |
|
|
2020
Q1 | $5.75M | Buy |
29,093
+230
| +0.8% | +$50.2K | 2.28% | 11 |
|
|
2019
Q4 | $6.94M | Sell |
28,863
-2,600
| -8% | -$573K | 2.14% | 12 |
|
|
2019
Q3 | $6.09K | Buy |
31,463
+222
| +0.7% | +$42.6K | 1.72% | 12 |
|
|
2019
Q2 | $5.76M | Sell |
31,241
-38,400
| -55% | -$6.88M | 1.97% | 12 |
|
|
2019
Q1 | $13.7M | Sell |
69,641
-2,363
| -3% | -$451K | 4.88% | 6 |
|
|
2018
Q4 | $14.9K | Hold |
72,004
| – | – | 4.75% | 7 |
|
|
2018
Q3 | $14.9K | Buy |
72,004
+1,549
| +2% | +$305K | 4.54% | 7 |
|
|
2018
Q2 | $13M | Buy |
70,455
+705
| +1% | +$125K | 4.91% | 6 |
|
|
2018
Q1 | $11.6M | Sell |
69,750
-3,825
| -5% | -$702K | 4.36% | 6 |
|
|
2017
Q4 | $14.3K | Buy |
+73,575
| New | +$13M | 3.93% | 6 |
|
|
2017
Q2 | $11.6M | Sell |
66,988
-681
| -1% | -$111K | 4.54% | 5 |
|
|
2017
Q1 | $11.1M | Buy |
+67,669
| New | +$11.2M | 4.96% | 5 |
|
|
2014
Q3 | $12.5M | Buy |
+67,165
| New | +$8.77M | 5.82% | 4 |
|
Other funds holding AMGN
VCM
VPM
Arthur M. Cohen & Associates's AMGN Position: Q1 2026 in Review
Arthur M. Cohen & Associates held its Amgen (AMGN) position steady in Q1 2026 at 4,206 shares worth $1.49M. The position accounts for 0.26% of the portfolio, ranked #54.
Arthur M. Cohen & Associates first reported a position in AMGN in Q3 2014 and has held it in 37 quarters since. The position peaked at $13.7M in Q1 2019. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Arthur M. Cohen & Associates held 4,206 shares of Amgen worth $1.49M as of Q1 2026.
- Arthur M. Cohen & Associates left its Amgen share count unchanged in Q1 2026.
- Amgen made up 0.26% of Arthur M. Cohen & Associates's portfolio in Q1 2026, its #54 holding.
- Arthur M. Cohen & Associates first reported a position in Amgen in Q3 2014 and has held it in 37 quarters since.
- Arthur M. Cohen & Associates's Amgen position peaked at $13.7M in Q1 2019.
- 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Arthur M. Cohen & Associates's 13F filing for Q1 2026, filed 8 May 2026.